Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Glucotrack (GCTK) reports successful completion of first human clinical study for continuous blood glucose monitoring, shares ...

The company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated ...

The external and internal jugular veins are joined by the subclavian vein, which enters the right atrium of the heart as the cranial vena cava (Fig. 1). Figure 1: Dissection of the cranial thorax ...

Glucotrack’s CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. For ...

Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...

The scan included the cervical portion of the jugular vein to the subclavian confluence and the upper extremity axillary and the subclavian vein segment in its entirety except for the subclavian ...

Glucotrack (GCTK) announced the successful completion of its first in human clinical study, marking a significant milestone in continuous ...

Glucotrack (Nasdaq:GCTK) announced today that it completed the first-in-human clinical study of its continuous blood glucose ...

A systematic review and meta-analysis found that real-time ultrasound guidance significantly increased the success rate of subclavian vein cannulation and reduced complication rates compared to ...

The femoral, jugular, subclavian, and cubital veins are the most frequently used sites for CVC insertion in children. In newborns, cubital veins and the saphenous vein are also frequently used for ...

RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ: GCTK), a medical technology company, announced the successful completion of its first in human clinical study for a novel continuous glucose monitoring ...